ClinicalTrials.Veeva

Menu

Normal Saline Versus Balance Salt Solution Resuscitation on Kidney Function

M

Mahidol University

Status

Unknown

Conditions

Shock
Acute Kidney Injury

Treatments

Drug: sterofundin
Drug: normal saline

Study type

Interventional

Funder types

Other

Identifiers

NCT02520804
Si566/2014

Details and patient eligibility

About

The purpose of this study is to determine Acute kidney injury incidence between sterofundin and normal saline ; Resuscitation shock patients

Full description

Sample size:Compare proportion for independent two groups formula. n=sample size α risk of 0.05, Statistical power of 80% P1 =incidence of acute kidney injury (AKI) in control (0.6)* P2 =incidence of acute kidney injury (AKI) in balanced salt solution (0.4)** from Ratanarat R,Hantaweepant C,Tangkawattanakul N,et al.The clinical outcome of acute kidney injury in critically ill Thai patients stratified with RIFLE classification.J Med Assoc Thai 2009 Mar;92 Suppl 2:61-7.

α risk of 0.05, Statistical power of 80%

Sample size for interim analysis 1.11 x 97 = 107.67 total 108 (at least 50 cases each arm)

Enrollment

107 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Shock patients (hypotension with signs of poor tissue perfusion)

Exclusion criteria

  • Age < 18 yr
  • Cardiogenic shock patients (History of ST elevation and Left ventricular ejection fraction (LVEF) < 35%),
  • Prolong shock >24 hrs,
  • Received chloride rich crystalloid (0.9% saline) or chloride rich colloid > 1000 ml within 72 hrs before recruitment
  • Do-not-resuscitation patients,
  • Contraindication for IV fluid administration such as pulmonary edema.,
  • Stage V chronic kidney disease (CKD),
  • chronic Hemodialysis or Peritonealdialyse

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

107 participants in 2 patient groups

normal saline
Active Comparator group
Description:
normal saline for fluid resuscitation and maintenance for 72 hours
Treatment:
Drug: normal saline
sterofundin
Experimental group
Description:
sterofundin for fluid resuscitation and maintenance for 72 hours
Treatment:
Drug: sterofundin

Trial contacts and locations

1

Loading...

Central trial contact

Ranistha Ratanarat, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems